![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Julien-Grille Sylvia Bellacosa Alfonso Larue Lionel
Publisher: Informa Healthcare
ISSN: 1473-3404
Source: The Women's Oncology Review, Vol.4, Iss.1, 2004-01, pp. : 13-15
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
miR320a is an independent prognostic biomarker for invasive breast cancer
Oncology Letters, Vol. 8, Iss. 3, 2014-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
PI3K/AKT pathway regulates E‐cadherin and Desmoglein 2 in aggressive prostate cancer
Cancer Medicine, Vol. 4, Iss. 8, 2015-08 ,pp. :